2019
DOI: 10.1016/j.cellsig.2019.109380
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of the FLVR motif of SHIP1 and its importance for the protein stability of SH2 containing signaling proteins

Abstract: Binding of proteins with SH2 domains to tyrosine-phosphorylated signaling proteins is a key mechanism for transmission of biological signals within the cell. Characterization of dysregulated proteins in cell signaling pathways is important for the development of therapeutic approaches. The AKT pathway is a frequently upregulated pathway in most cancer cells and the SH2-containing inositol 5-phosphatase SHIP1 is a negative regulator of the AKT pathway. In this study we investigated different mutations of the co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 35 publications
0
4
0
Order By: Relevance
“…In AML, recurrent mutations in the SHIP1-encoding gene INPP5D lead to a significantly reduced phosphatase activity 29 . To determine whether recurrent loss-of-function mutations in the SHIP1-encoding INPP5D gene also exist in CLL, we next identified the types and frequency of INPP5D alterations in CLL in publically available sequencing data 40 42 (using the cBioportal for Cancer Genomics platform ( http://cbioportal.org )) and compared them to INPP5D mutations previously found to reduce SHIP1 phosphatase activity 29 or protein stability 43 . In total, only 0.6% of CLL samples analyzed carried INPP5D gene alterations in CLL (6 mutations detected in 1048 analyzed CLL samples).…”
Section: Resultsmentioning
confidence: 99%
“…In AML, recurrent mutations in the SHIP1-encoding gene INPP5D lead to a significantly reduced phosphatase activity 29 . To determine whether recurrent loss-of-function mutations in the SHIP1-encoding INPP5D gene also exist in CLL, we next identified the types and frequency of INPP5D alterations in CLL in publically available sequencing data 40 42 (using the cBioportal for Cancer Genomics platform ( http://cbioportal.org )) and compared them to INPP5D mutations previously found to reduce SHIP1 phosphatase activity 29 or protein stability 43 . In total, only 0.6% of CLL samples analyzed carried INPP5D gene alterations in CLL (6 mutations detected in 1048 analyzed CLL samples).…”
Section: Resultsmentioning
confidence: 99%
“…Similar effects can be observed after lentiviral transduction of SHIP1 in the AML cell line UKE1 [ 56 , 59 ]. In contrast, little to no reduction in SHIP1 protein expression was found in two other cell lines (H1299 and Reh), which were handled according to the same routine ( Figure S4 ) [ 40 , 59 ]. In the future, these experiments (determination of the SHIP1 status and reconstitution of SHIP1 expression) should be carried out with other suitable T-ALL cell lines and primary cells.…”
Section: Discussionmentioning
confidence: 99%
“…Western blot analysis was performed as described previously [ 40 ]. Protein lysates were prepared by lysing cells in trichloroacetic acid.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation